Kingsview Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Kingsview Wealth Management’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$50.4K	Sell
2025 Q3	$159K	Sell
2025 Q2	$519K	Buy
2025 Q1	$90.1K	Sell
2024 Q4	$120K	Sell
2024 Q3	$149K	Sell
2024 Q2	$174K	Sell
2024 Q1	$240K	Buy